Respiratory allergic diseases and allergen immunotherapy: A French patient survey before and during the COVID-19 pandemic

Background: The COVID-19 pandemic brought unprecedented global disruption to both healthcare providers and patients with respiratory allergies. There are limited real-life data on the impact of the COVID-19 pandemic on the risk perception of patients with allergy treated with allergen immunotherapy...

Full description

Bibliographic Details

Published in:	World Allergy Organization Journal
Main Authors:	Philippe Devillier, MD, PhD, Sarah Saf, MD, Christine Rolland, BA, Giorgio Walter Canonica, MD, Pascal Demoly, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Subjects:	COVID-19 Allergen immunotherapy Respiratory allergy Allergic rhinitis Asthma
Online Access:	http://www.sciencedirect.com/science/article/pii/S1939455124000334